Search - tctmd.com

Displaying 221 - 240 of 261

Sort: Relevancy | Date

Presentation CIT 2014

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

Presenter: M Bedossa

March 22, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Lisette Okkels Jensen

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Presenter: Gianluca Campo

October 23, 2013

Presentation

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Presenter: M. Jin

August 27, 2013

Presentation

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Presenter: Tarun W. Dasari

August 21, 2013

Presentation

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Presenter: Gert Richardt

August 14, 2013

Presentation SOLACI 2013

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

Presenter: Roxana Mehran

July 25, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Presentation CIT 2013

Coronary In-stent Restenosis: A Settled Clinical Indication in the DES World ?

Presenter: Kenneth Chin

March 22, 2013

Presentation TCT 2013

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Presenter: Piero Montorsi, Antonio Bartorelli, Franco Fabbiocchi, Stefano Galli, Alessandro Lualdi, Paolo Ravagnani, Giovanni Teruzzi, Daniela Trabattoni, Sarah Troiano

January 31, 2013

Presentation TCT 2013

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

Presenter: Sanghoon Shin, Donghoon Choi, Young-Guk Ko

January 31, 2013

$The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...$

Presentation TCT 2013

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Presenter: Tahei Ichinohe, Kazushige Kadota, Haruki Eguchi, Seiji Habara, Hiroyuki Tanaka, Takeshi Tada, Yasushi Fuku, Naoki Oka, Hiroyuki Yamamoto, Satoki Fujii, Tsuyoshi Goto, Kazuaki Mitsudo

January 31, 2013

Presentation TCT 2013

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Presenter: Piotr Buszman, Taylor Palmieri, Maxwell Afari, Armando Tellez, Yanping Cheng, Jong Shiuan Yeh, Seung-Jin Oh, Greg Kaluza, Juan Granada

January 31, 2013

Advertisement

Clinical outcomes of paclitaxel coated balloon angioplasty in an unselected patient population with drug eluting stent in-stent restenosis: Results from the French GARO Registry

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Case II: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Higher Risk of Recurrent Ischemic Events in Patients with Intracranial In-Stent Restenosis

Systematic Review of Oral Sirolimus After Bare-Metal Stenting of Coronary Arteries for Prevention of In-Stent Restenosis

Clinical Outcomes of the Resolute ZES in Patients With In-Stent Restenosis

Dealing with In-Stent Restenosis: Mechanisms, Predictors, and Clinical Implications

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Coronary In-stent Restenosis: A Settled Clinical Indication in the DES World ?

Use Of Drug-Eluting Balloon For The Treatment Of In-stent Restenosis After Carotid Artery Stenting

Totally Occluded In-stent Restenosis After Superficial Femoral Artery Stenting does not Worsen the Long-term Outcomes, but tend to Recur Occlusively

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after...

Predictors of In Stent Restenosis by Optical Coherence Tomography Derived Tissue Characterization In The Novel In Stent Neointimal Hyperplasia Model Of Familial...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content